Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

ALX Oncology Holdings Inc. - Common Stock (NQ:ALXO)

0.6443 -0.0107 (-1.63%)
Streaming Delayed Price Updated: 4:00 PM EDT, Aug 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 219,713
Open 0.6404
Bid (Size) 0.6505 (81)
Ask (Size) 0.6848 (20)
Prev. Close 0.6550
Today's Range 0.6245 - 0.6692
52wk Range 0.4040 - 2.730
Shares Outstanding 40,869,135
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
ALX Oncology Holdings Inc (NASDAQ:ALXO) Reports Q2 2025 Results with Wider Loss but Strong Clinical Progress
ALX Oncology reports Q2 2025 results with a net loss of $25.9M, wider than expected, but shares dip only slightly. Clinical progress, including evorpacept data and ALX2004 trials, remains key focus.... 
Via Chartmill

Performance

YTD
-58.7%
-58.7%
1 Month
+31.0%
+31.0%
3 Month
+49.4%
+49.4%
6 Month
-45.4%
-45.4%
1 Year
-74.6%
-74.6%

More News

Read More
ALX Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update
From ALX Oncology
Via GlobeNewswire
ALX Oncology Holdings's Earnings: A Preview
Via Benzinga
Earnings Scheduled For May 8, 2025
Via Benzinga
What's Next: ALX Oncology Holdings's Earnings Preview
Via Benzinga
Earnings Scheduled For August 12, 2025
Via Benzinga
ALX Oncology to Report Second Quarter 2025 Financial Results on August 12, 2025
From ALX Oncology
Via GlobeNewswire
Top movers in Tuesday's after hours session
Via Chartmill
ALX Oncology to Present at the Jefferies 2025 Global Healthcare Conference
From ALX Oncology
Via GlobeNewswire
ALX Oncology Highlights Differentiated Design, Preclinical Data and Development Plans for EGFR-Targeted ADC, ALX2004, in R&D Webcast Event
From ALX Oncology
Via GlobeNewswire
ALX Oncology to Host R&D Webcast Event Highlighting its Novel EGFR Targeting Antibody-Drug Conjugate, ALX2004, on May 20, 2025
From ALX Oncology
Via GlobeNewswire
ALX Oncology Reports First Quarter 2025 Financial Results and Provides Corporate Update
From ALX Oncology
Via GlobeNewswire
ALX Oncology to Report First Quarter 2025 Financial Results on May 8, 2025
From ALX Oncology
Via GlobeNewswire
ALX Oncology Announces Encouraging Final Results from Phase 1 Trial Evaluating Evorpacept in Combination with Standard-of-Care Treatment in Patients with B-cell Non-Hodgkin Lymphoma
From ALX Oncology
Via GlobeNewswire
ALX Oncology Reports ASPEN-03 and ASPEN-04 Phase 2 Trials Evaluating Evorpacept with a Checkpoint Inhibitor for the Treatment of Head and Neck Cancers Did Not Meet Primary Endpoints
From ALX Oncology
Via GlobeNewswire
ALX Oncology Receives IND Clearance from U.S. FDA for ALX2004, a Novel EGFR-targeted Antibody-drug Conjugate
From ALX Oncology
Via GlobeNewswire
ALX Oncology Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
From ALX Oncology
Via GlobeNewswire
Which stocks are moving on Thursday?
Via Chartmill
Top movers in Thursday's session
Via Chartmill
This Zscaler Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday
Via Benzinga
ALX Oncology Highlights Focused Evorpacept Development Plan, Clinical Progress and Corporate Updates at R&D Day Webcast Event
From ALX Oncology
Via GlobeNewswire
ALX Oncology to Report Fourth Quarter and Full Year 2024 Financial Results on March 6, 2025
From ALX Oncology
Via GlobeNewswire
Earnings Scheduled For March 6, 2025
Via Benzinga
ALX Oncology to Host Virtual R&D Day on March 5, 2025
From ALX Oncology
Via GlobeNewswire

Frequently Asked Questions

Is ALX Oncology Holdings Inc. - Common Stock publicly traded?
Yes, ALX Oncology Holdings Inc. - Common Stock is publicly traded.
What exchange does ALX Oncology Holdings Inc. - Common Stock trade on?
ALX Oncology Holdings Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for ALX Oncology Holdings Inc. - Common Stock?
The ticker symbol for ALX Oncology Holdings Inc. - Common Stock is ALXO on the Nasdaq Stock Market
What is the current price of ALX Oncology Holdings Inc. - Common Stock?
The current price of ALX Oncology Holdings Inc. - Common Stock is 0.6443
When was ALX Oncology Holdings Inc. - Common Stock last traded?
The last trade of ALX Oncology Holdings Inc. - Common Stock was at 08/15/25 04:00 PM ET
What is the market capitalization of ALX Oncology Holdings Inc. - Common Stock?
The market capitalization of ALX Oncology Holdings Inc. - Common Stock is 26.33M
How many shares of ALX Oncology Holdings Inc. - Common Stock are outstanding?
ALX Oncology Holdings Inc. - Common Stock has 26M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.